DNTH Dianthus Therapeutics Inc.

USD 26.35 -1.33 ( -4.80)%
Icon

Dianthus Therapeutics Inc. (DNTH) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 26.35

-1.33 (-4.80)%

N/A

0.24M

USD 43.82(+66.29%)

N/A

Icon

DNTH

Dianthus Therapeutics Inc. (USD)
COMMON STOCK | NSD
USD 26.35
-1.33 ( -4.80)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 26.35

Dianthus Therapeutics Inc. (DNTH) Stock Forecast

Show ratings and price targets of :
USD 43.82
(+66.29%)

Based on the Dianthus Therapeutics Inc. stock forecast from 6 analysts, the average analyst target price for Dianthus Therapeutics Inc. is USD 43.82 over the next 12 months. Dianthus Therapeutics Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Dianthus Therapeutics Inc. is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Dianthus Therapeutics Inc.’s stock price was USD 26.35. Dianthus Therapeutics Inc.’s stock price has changed by -10.40% over the past week, -4.18% over the past month and +132.98% over the last year.

No recent analyst target price found for Dianthus Therapeutics Inc.
No recent average analyst rating found for Dianthus Therapeutics Inc.

Company Overview Dianthus Therapeutics Inc.

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Dianthus Therapeutics Inc. (DNTH)

Loading...

Unadjusted Closing Price for Dianthus Therapeutics Inc. (DNTH)

Loading...

Share Trading Volume for Dianthus Therapeutics Inc. Shares

Loading...

Compare Performance of Dianthus Therapeutics Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for DNTH

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Dianthus Therapeutics Inc. (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.61 (+0.94%) USD121.60B 32.57 250.99

Frequently Asked Questions About Dianthus Therapeutics Inc. (DNTH) Stock

Based on ratings from 6 analysts Dianthus Therapeutics Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bullish. The stock has 11 buy, sell and hold ratings.

Unfortunately we do not have enough data on DNTH's stock to indicate if its a good dividend stock.

Based on targets from 6 analysts, the average taret price for DNTH is USD 43.82 over the next 12 months. The maximum analyst target price is USD 58 while the minimum anlayst target price is USD 36.

Unfortunately we do not have enough data on DNTH's stock to indicate if its overvalued.

The last closing price of DNTH's stock was USD 26.35.

Unfortunately we do not currently have any market capitalization data for DNTH's stock.

Based on targets from 6 analysts, the average taret price for DNTH is projected at USD 43.82 over the next 12 months. This means that DNTH's stock price may go up by +66.29% over the next 12 months.

We can't find any ETFs which contains Dianthus Therapeutics Inc.'s stock.

Sorry, we do not have any data on the number of employees for Dianthus Therapeutics Inc..

Sorry we do not have any infomation available on Dianthus Therapeutics Inc.'s address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Dianthus Therapeutics Inc. (DNTH) Stock

Based on ratings from 6 analysts Dianthus Therapeutics Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bullish. The stock has 11 buy, sell and hold ratings.

Unfortunately we do not have enough data on DNTH's stock to indicate if its a good dividend stock.

Based on targets from 6 analysts, the average taret price for DNTH is USD 43.82 over the next 12 months. The maximum analyst target price is USD 58 while the minimum anlayst target price is USD 36.

Unfortunately we do not have enough data on DNTH's stock to indicate if its overvalued.

The last closing price of DNTH's stock was USD 26.35.

Unfortunately we do not currently have any market capitalization data for DNTH's stock.

Based on targets from 6 analysts, the average taret price for DNTH is projected at USD 43.82 over the next 12 months. This means that DNTH's stock price may go up by +66.29% over the next 12 months.

We can't find any ETFs which contains Dianthus Therapeutics Inc.'s stock.

Sorry, we do not have any data on the number of employees for Dianthus Therapeutics Inc..

Sorry we do not have any infomation available on Dianthus Therapeutics Inc.'s address.
Loading...